Yuji Takei

Shimotsuke, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 110 publications

Progesterone Is Associated With Increased Vasohibin-2 Expression, Tubulin Detyrosination, and Paclitaxel Sensitivity in PR-Negative Ovarian Cancer Cells.

Progesterone Is Associated With Increased Vasohibin-2 Expression, Tubulin Detyrosination, and Paclitaxel Sensitivity in PR-Negative Ovarian Cancer Cells.

Journal: Cancer reports (Hoboken, N.J.)

Published: March 21, 2026

Recovery from severe adriamycin-induced cardiomyopathy after prolonged intensive care in a patient with uterine leiomyosarcoma: A case report.

Recovery from severe adriamycin-induced cardiomyopathy after prolonged intensive care in a patient with uterine leiomyosarcoma: A case report.

Journal: Experimental and therapeutic medicine

Published: February 21, 2026

Progesterone Enhances the Sensitivity of Ovarian Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibitors by Suggesting a Role for Transcription-Replication Conflict-Related Pathways: An In Vitro Study.

Progesterone Enhances the Sensitivity of Ovarian Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibitors by Suggesting a Role for Transcription-Replication Conflict-Related Pathways: An In Vitro Study.

Journal: Cureus

Published: January 17, 2026

Acute myocardial infarction caused by coronary tumor embolism from uterine leiomyosarcoma: a case report.

Acute myocardial infarction caused by coronary tumor embolism from uterine leiomyosarcoma: a case report.

Journal: Gynecologic oncology reports

Published: January 14, 2026

Impact of prior PARP inhibitor exposure on the efficacy of platinum-based chemotherapy in platinum-sensitive recurrent ovarian cancer: a propensity score-matched analysis.

Impact of prior PARP inhibitor exposure on the efficacy of platinum-based chemotherapy in platinum-sensitive recurrent ovarian cancer: a propensity score-matched analysis.

Journal: International journal of clinical oncology

Published: December 19, 2025

Combined Intraperitoneal and Systemic Chemotherapy for Peritoneal Metastases: Drug Delivery Concepts, Pharmacokinetics, and Clinical Applications: A Narrative Review.

Combined Intraperitoneal and Systemic Chemotherapy for Peritoneal Metastases: Drug Delivery Concepts, Pharmacokinetics, and Clinical Applications: A Narrative Review.

Journal: Pharmaceutics

Published: December 18, 2025

Severe Lymphorrhea Mimicking Hypovolemic Shock Following Retroperitoneal Lymphadenectomy for Endometrial Cancer: A Case Report.

Severe Lymphorrhea Mimicking Hypovolemic Shock Following Retroperitoneal Lymphadenectomy for Endometrial Cancer: A Case Report.

Journal: The journal of obstetrics and gynaecology research

Published: December 08, 2025

Efficacy of lenvatinib plus pembrolizumab for recurrent endometrial cancer: a focus on the nonendometrioid histology including carcinosarcoma.

Efficacy of lenvatinib plus pembrolizumab for recurrent endometrial cancer: a focus on the nonendometrioid histology including carcinosarcoma.

Journal: Japanese journal of clinical oncology

Published: November 17, 2025

Preoperative Diagnosis of Small Bowel Metastasis of Ovarian Clear Cell Carcinoma Using Capsule and Double-Balloon Endoscopy: A Case Report.

Preoperative Diagnosis of Small Bowel Metastasis of Ovarian Clear Cell Carcinoma Using Capsule and Double-Balloon Endoscopy: A Case Report.

Journal: The journal of obstetrics and gynaecology research

Published: July 29, 2025

Prognostic factors for malignant tumors arising from mature cystic teratomas: a study involving the Kansai Clinical Oncology Group (KCOG-G1305s study).

Prognostic factors for malignant tumors arising from mature cystic teratomas: a study involving the Kansai Clinical Oncology Group (KCOG-G1305s study).

Journal: Archives of gynecology and obstetrics

Published: May 29, 2025

Prognostic impact of lymphadenectomy in patients with advanced ovarian clear cell carcinoma: an ancillary analysis of the JGOG3017-A4 study.

Prognostic impact of lymphadenectomy in patients with advanced ovarian clear cell carcinoma: an ancillary analysis of the JGOG3017-A4 study.

Journal: International journal of clinical oncology

Published: May 16, 2025

Pneumothorax during lenvatinib plus pembrolizumab for recurrent endometrial cancer: A case report.

Pneumothorax during lenvatinib plus pembrolizumab for recurrent endometrial cancer: A case report.

Journal: Taiwanese journal of obstetrics & gynecology

Published: March 08, 2025

Showing 1-12 of 110

Last Updated: 09/26/2026